Analyzing Non-Tariff Barriers in Sino-Indian Trade: Challenges for Market Access

The persistent imbalance in bilateral trade between India and China continues to be a focal point of economic policy discourse. Recent statements by the Finance Minister highlight that the widening trade deficit is not merely a consequence of market demand but is significantly exacerbated by complex non-tariff barriers (NTBs) imposed by the Chinese administration. While tariff regimes are often discussed in trade negotiations, NTBs—such as stringent sanitary and phytosanitary (SPS) measures, technical barriers to trade (TBT), cumbersome licensing requirements, and restrictive regulatory audits—effectively create a 'glass ceiling' for Indian exporters. Key sectors such as pharmaceuticals, particularly generic medicines, and agricultural produce have faced systematic exclusion from the Chinese market despite India’s competitive advantage in these domains. These measures function as disguised protectionism, ensuring that while India remains a substantial consumer of Chinese manufactured goods and capital equipment, its own high-value exports face insurmountable regulatory hurdles. This asymmetry undermines the objective of building a balanced, reciprocal trade relationship.